Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06087978 · ClinicalTrials.gov registry record · Phase 1
Study of RPT193 in Healthy Adult Male Subjects
A Phase 1 study, sponsored by RAPT Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT06087978 is a Phase 1 study that has completed, run by RAPT Therapeutics. The registered enrollment target is 7 participants.
The verdict
NCT06087978, a Phase 1 study, has completed, sponsored by RAPT Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
Phase 1, open-label, absorption, metabolism, excretion, and mass balance study.
Interventions
- DRUG 14C RPT193
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2023-10-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06087978
The ClinicalTrials.gov registry entry for NCT06087978 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAPT Therapeutics, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 14C RPT193 is the first listed.
NCT06087978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06087978 about?
NCT06087978 is a clinical study titled "Study of RPT193 in Healthy Adult Male Subjects". Phase 1, open-label, absorption, metabolism, excretion, and mass balance study.
What is the current status of trial NCT06087978?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2023-07-05. Estimated completion is 2023-10-12.
What interventions are being tested in trial NCT06087978?
The interventions under investigation include: 14C RPT193 (DRUG).
Who is sponsoring clinical trial NCT06087978?
This trial is sponsored by RAPT Therapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.